Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Breast cancer
  • (-) = Nortier, J.W.R.
  • (-) = Velde, C.J.H. van de

Search results

  • RSS Feed
(1 - 12 of 12)
Strong CD8+lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
Groot, A.F. de; Blok, E.J.; Charehbili, A.; Engels, C.C.; Smit, V.T.H.B.M.; Dekker-Ensink, N.G.; ... ; Kroep, J.R. 2019
Strong CD8+lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
Article / Letter to editor
metadata only
Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer
Blok, E.J.; Kroep, J.R.; Kranenbarg, E.M.K.; Duijm-De Carpentier, M.; Putter, H.; Liefers, G.J.; ... ; TEAM Study Group 2018
Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer
Article / Letter to editor
metadata only
Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04)
Fontein, D.B.Y.; Charehbili, A.; Nortier, J.W.R.; Putter, H.; Kranenbarg, E.M.K.; Kroep, J.R.; ... ; Velde, C.J.H. van de 2017
Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04)
Article / Letter to editor
metadata only
Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)
Charehbili, A.; Hamdy, N.A.T.; Smit, V.T.H.B.M.; Kessels, L.; Bochove, A. van; Laarhoven, H.W. van; ... ; Dutch Breast Canc Res Grp BOOG 2016
Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)
Article / Letter to editor
metadata only
Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients
Kool, M.; Fontein, D.B.Y.; Kranenbarg, E.M.K.; Nortier, J.W.R.; Rutgers, E.J.T.; Marang-van de Mheen, P.J.; Velde, C.J.H. van de 2015
Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients
Article / Letter to editor
metadata only
Disorganised stroma determined on pre-treatment breast cancer biopsies is associated with poor response to neoadjuvant chemotherapy: Results from the NEOZOTAC trial
Dekker, T.J.A.; Charehbili, A.; Smit, V.T.H.B.M.; Dijke, P. ten; Kranenbarg, E.M.K.; Velde, C.J.H. van de; ... ; Kroep, J.R. 2015
Disorganised stroma determined on pre-treatment breast cancer biopsies is associated with poor response to neoadjuvant chemotherapy: Results from the NEOZOTAC trial
Article / Letter to editor
metadata only
Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
Groot, S. de; Janssen, L.G.M.; Charehbili, A.; Dijkgraaf, E.M.; Smit, V.T.H.B.M.; Kessels, L.W.; ... ; Kroep, J.R. 2015
Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
Article / Letter to editor
metadata only
Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients - A phase II trial
Fontein, D.B.Y.; Charehbili, A.; Nortier, J.W.R.; Kranenbarg, E.M.K.; Kroep, J.R.; Putter, H.; ... ; Velde, C.J.H. van de 2014
Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients - A phase II trial
Article / Letter to editor
metadata only
Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial
Fontein, D.B.Y.; Houtsma, D.; Nortier, J.W.R.; Baak-Pablo, R.F.; Kranenbarg, E.M.K.; Straaten, T.R.J.H.M. van der; ... ; Guchelaar, H.J. 2014
Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial
Article / Letter to editor
metadata only
Neoadjuvant hormonal therapy for endocrine sensitive breast cancer: A systematic review
Charehbili, A.; Fontein, D.B.Y.; Kroep, J.R.; Liefers, G.J.; Mieog, J.S.D.; Nortier, J.W.R.; Velde, C.J.H. van de 2014
Neoadjuvant hormonal therapy for endocrine sensitive breast cancer: A systematic review
Article / Letter to editor
metadata only
Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - A TEAM study analysis
Water, W. van de; Fontein, D.B.Y.; Nes, J.G.H. van; Bartlett, J.M.S.; Hille, E.T.M.; Putter, H.; ... ; Velde, C.J.H. van de 2013
Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - A TEAM study analysis
Article / Letter to editor
metadata only
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study
Nes, J.G.H. van; Fontein, D.B.Y.; Hille, E.T.M.; Voskuil, D.W.; Leeuwen, F.E. van; Haes, J.C.J.M. de; ... ; Velde, C.J.H. van de 2012
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study
Article / Letter to editor
metadata only